Infinium Pharmachem IPO

Infinium Pharmachem IPO will open for subscription from 31 March 2023. the company aims for an issue size of ₹25.26 Cr through this IPO.

About Company

Incorporated in 2003, Infinium Pharmachem aims to manufacture and supply Iodine, Iodine Derivatives, and Active Pharmaceutical Ingredients (APIs). The company undertakes contract research and manufacturing services to provide customized and fully confidential solutions to its clients. Today, its manufacturing capabilities and technical expertise has allowed it to efficiently cater to numerous industries such as pharmaceutical & biotech, specialty & Performance chemicals, agrochemicals, human health, animal health, cosmetics, sanitation, electrical, electronics, and much more. Its manufacturing plant in Gujarat, provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs.

Basic details about the company

Full name	Infinium Pharmachem Limited
Sector	Chemicals
Industry	Chemicals
Company Website	https://infiniumpharmachem.com/

The objective of the Issue

Marketing and branding expenses (including registration in reach – Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
4. To meet public issue expenses.

IPO Timetable

IPO Opening date	31 March 2023
IPO Closing	05 April 2023
Basis of Allotment	11 April 2023
Initiation Refund	12 April 2023
Credit to Demat Account	13 April 2023
Listing Date	17 April 2023

IPO details

Issue type	Fixed Price Issue IPO
IPO issue size	₹25.26 Cr – 1,875,000 shares
Fresh Issue	₹25.26 Cr – 1,875,000 shares
Offer for sale	Nil
Face value	₹10 per share
Offer Price	₹135 per share
Lot size	1000 Shares
Retail Allocation	50%
Listing Exchange	NSE SME

IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	1	1000	₹135,000
Retail (Max)	1	1000	₹135,000
HNI (Min)	2	2,000	₹270,000

Reservation Details

QIB Shares Offered	Nil
NII (HNI) Shares Offered	50%
Retail Shares Offered	50%

Financial Performance

	FY 2020	FY 2021	FY 2022	H1 FY 2023
Revenue	38.84	70.53	99.12	79.28
Expenses	38.18	67.38	91.42	72.17
Net income	0.87	2.73	6.69	6.0

(Amount in ₹ Crors)

Valuations & Margins

	FY 2020	FY 2021	FY 2022
EPS	2.01	5.35	12.01
PE ratio	–	–	11.24
RONW (%)	21.99	38.80	46.61
NAV	–	–	72.24
ROCE (%)	57.0	68.0	74.0
EBITDA (%)	7.88	7.91	11.07
Debt/Equity	4.17	3.74	3.24

Company Promoters

Mr. Sanjaykumar Viththalbhai Patel
Mr. Pravin Bhadabhai Madhani
Mr. Mitesh Lavjibhai Chikhaliya

Promoter Holding

Pre Issue Share Holding	100%
Post Issue Share Holding

Lead Manager(s)

Swastika Investmart Ltd

IPO Registrar

BIGSHARE SERVICES PRIVATE LIMITED
Office No. S6-2, 6th Floor,
Pinnacle Business Park,
Next to Ahura Centre, Mahakali
Caves Road, Andheri East,
Mumbai – 400 093
Telephone: +91 22 6263 8200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com

Contact Details

INFINIUM PHARMACHEM LIMITED
Suite 205, Sigma Prime, 2nd Floor,
Nr. Sardar Patel Statue Vallabh Vidhyanagar,
Dist. Anand – 388120, Gujarat
Phone: +91 (2692) 238849, 238850, 297446
E-mail: cs@infiniumpharmachem.com
Website: www.infiniumpharmachem.com

Allotment Status

Infinium Pharmachem IPO allotment status will be available on Bigshare Services’ website. Click on Bigshare Services weblink to get allotment status.

Final thoughts

Infinium Pharmachem IPO is going to hit Dalal street soon. applying for an IPO is purely a personal choice. study well about the company and do subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.

Happy Investing